Latest Blog Posts
Search
Sort Results
Filter by Specific Population
Filter by Topic
Filter by Infection
Filter by Resource Category
- Research summary (remove)
Search results
Current filters: HIV, Treatment, HIV drugs, Research summary
116 search results
- Dolutegravir and TAF or TDF—safety issues and weight gain
-
From TreatmentUpdate 235
2020, CATIE
Research summary - Webpage - From wasting to obesity—the changing issue of weight in HIV
-
From TreatmentUpdate 235
2020, CATIE
Research summary - Webpage - Fostemsavir compassionate access program
-
From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage - Fostemsavir in treatment-experienced people
-
From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage - The debut of fostemsavir
-
From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage - Doravirine begins to be listed on formularies
-
From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage - Decreasing the risk of neural tube defects with dolutegravir
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - Some issues to consider with Dovato (dolutegravir + 3TC)
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - Switching to Dovato (dolutegravir + 3TC) from a TAF-based regimen
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - Dovato (dolutegravir + 3TC) in initial HIV treatment
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage
